99 related articles for article (PubMed ID: 33276293)
1. Rewiring Tumor Cell State in Cancer Therapy: Comment on '9-cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts' by 'Elizabeth Beierle et al.'.
Chakraborty AA
Transl Oncol; 2021 Jan; 14(1):100967. PubMed ID: 33276293
[No Abstract] [Full Text] [Related]
2. 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts.
Marayati R; Bownes LV; Stafman LL; Williams AP; Quinn CH; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
Transl Oncol; 2021 Jan; 14(1):100893. PubMed ID: 33010553
[TBL] [Abstract][Full Text] [Related]
3. Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts.
Marayati R; Bownes LV; Quinn CH; Wadhwani N; Williams AP; Markert HR; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
J Pediatr Surg; 2021 Jun; 56(6):1165-1173. PubMed ID: 33762121
[TBL] [Abstract][Full Text] [Related]
4. UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts.
Williams AP; Garner EF; Stafman LL; Aye JM; Quinn CH; Marayati R; Stewart JE; Atigadda VR; Mroczek-Musulman E; Moore BP; Beierle EA; Friedman GK
Transl Oncol; 2019 Oct; 12(10):1364-1374. PubMed ID: 31362265
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
Mol Cancer Ther; 2015 Jul; 14(7):1559-69. PubMed ID: 25944918
[TBL] [Abstract][Full Text] [Related]
6. A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.
Williams AP; Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
J Surg Res; 2018 Aug; 228():54-62. PubMed ID: 29907230
[TBL] [Abstract][Full Text] [Related]
7. The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis.
Chou CF; Hsieh YH; Grubbs CJ; Atigadda VR; Mobley JA; Dummer R; Muccio DD; Eto I; Elmets CA; Garvey WT; Chang PL
J Dermatol Sci; 2018 Jun; 90(3):343-356. PubMed ID: 29599065
[TBL] [Abstract][Full Text] [Related]
8. Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.
Kapetanovic IM; Horn TL; Johnson WD; Cwik MJ; Detrisac CJ; McCormick DL
Int J Toxicol; 2010; 29(2):157-64. PubMed ID: 20335511
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies.
Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
Mol Cancer Ther; 2016 May; 15(5):911-21. PubMed ID: 26873726
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
Grubbs CJ; Lubet RA; Atigadda VR; Christov K; Deshpande AM; Tirmal V; Xia G; Bland KI; Eto I; Brouillette WJ; Muccio DD
Carcinogenesis; 2006 Jun; 27(6):1232-9. PubMed ID: 16344269
[TBL] [Abstract][Full Text] [Related]
11. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells.
Naveen CR; Gaikwad S; Agrawal-Rajput R
Phytomedicine; 2016 Jun; 23(7):736-44. PubMed ID: 27235712
[TBL] [Abstract][Full Text] [Related]
12. PlGF Knockdown Decreases Tumorigenicity and Stemness Properties of Spheroid Body Cells Derived from Gastric Cancer Cells.
Mahmoodi F; Akrami H
J Cell Biochem; 2017 Apr; 118(4):851-859. PubMed ID: 27735991
[TBL] [Abstract][Full Text] [Related]
13. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
Wagner CE; Jurutka PW
Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
[TBL] [Abstract][Full Text] [Related]
14. In vitro assessment of P450 induction potential of novel chemopreventive agents SR13668, 9-cis-UAB30, and pentamethychromanol in primary cultures of human hepatocytes.
Jackson JP; Kabirov KK; Kapetanovic IM; Lyubimov A
Chem Biol Interact; 2009 May; 179(2-3):263-72. PubMed ID: 19135037
[TBL] [Abstract][Full Text] [Related]
15. Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMN.
Jurutka PW; Wagner CE
Methods Mol Biol; 2019; 2019():95-108. PubMed ID: 31359391
[TBL] [Abstract][Full Text] [Related]
16. Β-carotene inhibits neuroblastoma tumorigenesis by regulating cell differentiation and cancer cell stemness.
Lim JY; Kim YS; Kim KM; Min SJ; Kim Y
Biochem Biophys Res Commun; 2014 Aug; 450(4):1475-80. PubMed ID: 25019987
[TBL] [Abstract][Full Text] [Related]
17. Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts.
Stafman LL; Williams AP; Marayati R; Aye JM; Markert HR; Garner EF; Quinn CH; Lallani SB; Stewart JE; Yoon KJ; Whelan K; Beierle EA
Sci Rep; 2019 Sep; 9(1):13259. PubMed ID: 31519958
[TBL] [Abstract][Full Text] [Related]
18. Anti-cancer stemness and anti-invasive activity of bitter taste receptors, TAS2R8 and TAS2R10, in human neuroblastoma cells.
Seo Y; Kim YS; Lee KE; Park TH; Kim Y
PLoS One; 2017; 12(5):e0176851. PubMed ID: 28467517
[TBL] [Abstract][Full Text] [Related]
19. Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma.
Bayat Mokhtari R; Baluch N; Ka Hon Tsui M; Kumar S; S Homayouni T; Aitken K; Das B; Baruchel S; Yeger H
BMC Cancer; 2017 Feb; 17(1):156. PubMed ID: 28235409
[TBL] [Abstract][Full Text] [Related]
20. SLC34A2 promotes neuroblastoma cell stemness via enhancement of miR-25/Gsk3β-mediated activation of Wnt/β-catenin signaling.
Chen J; Wang P; Cai R; Peng H; Zhang C; Zhang M
FEBS Open Bio; 2019 Mar; 9(3):527-537. PubMed ID: 30868061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
